Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Comparative Bioavailability Study of Ketamine and Norketamine After Single Dose Administration of Ketamine 10, 20, 40 and 80 mg Prolonged Release Tablets in Fasting State and 5 mg Ketamine Solution for Infusion in 15 Healthy Subjects in Serum, Urine and Feces


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02494830

Organisation Name: University Medicine Greifswald

Overal Status: Completed

Start Date: August 2014

Last Update: July 10, 2015

Lead Sponsor: University Medicine Greifswald

Brief Summary: This study is designed for descriptive pharmacokinetic characterization of ketamine and norketamine in serum, urine and feces after oral single dose administration of a new developed prolonged release tablet formulation containing 10, 20, 40 and 80 mg ketamine under fasting conditions and for descriptive pharmacokinetic characterization of ketamine and norketamine in serum, urine and feces after intravenous single dose administration of 5 mg ketamine solution for infusion within 30 min

Conditions:
  • Healthy


Total execution time in seconds: 0.2044050693512